Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.246 EUR | -5.46% |
|
-8.78% | -3.26% |
06-14 | Abionyx: positive response from FDA, share price rises | CF |
06-13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.26% | 45.48M | |
+15.28% | 122B | |
+20.24% | 113B | |
+8.24% | 22.84B | |
-20.54% | 20.72B | |
-16.19% | 16.51B | |
-13.40% | 16.39B | |
-44.35% | 15.83B | |
+1.23% | 13.49B | |
+65.72% | 11.67B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- ABIONYX Pharma SA Announces Resignation of Richard Pasternak as Director and Chairman